University of Baghdad



C.V

Name: Mohammed Hassan Mohammed

Date of Birth: 2/3/1966

Religion: Muslim

Martial statues: Married

No. of children: 4

Specialization: Pharmaceutical Chemistry

Position: Doctorate

Scientific Degree: Assistant Professor

Work Address: Baghdad University/ Pharmacy College

Work Phone:

Mobile:

E-mail:dr.mhassnm666666@

• First, Scientific Certification:

|Date |College |University |Degree science |

|1990 |Pharmacy |Baghdad |B.Sc. |

|1977 |Pharmacy |Baghdad |M.Sc. |

|2006 |Pharmacy |Baghdad |Ph.D. |

| | | |Any other |

|From -To |Workplace |Career |No. |

| |Baghdad University/Pharmacy College College |Consume |1 |

| |Baghdad University/Pharmacy College |Assistant lecture |2 |

| |Baghdad University/Pharmacy College |Lecture |3 |

| |Baghdad University/Pharmacy College |Assistant professor |4 |

| | | |5 |

| | | |6 |

• Second, Career:

• Third, University Teaching.

|From -To |The (Institute / College) |University |No. |

| 1992- |Pharmacy College |Baghdad |1 |

|2009-2013 |Pharmacy College |Howler |2 |

|2000-2016 |Pharmacy College |Baghdad Pharmacy |3 |

| | | |4 |

| | | |5 |

| | | |6 |

| | | |7 |

• Fourth, Courses Which You Teach:

|Year |Subject |Department |No. |

| |Analytical Chemistry |Pharmaceutical Chemistry |1 |

| |Organic Chemistry |Pharmaceutical Chemistry |2 |

| |Inorganic Pharmaceutical Chemistry Chemisss |Pharmaceutical Chemistry |3 |

| |Organic Pharmaceutical Chemistry 1 |Pharmaceutical Chemistry |4 |

| |Organic Pharmaceutical Chemistry 2 |Pharmaceutical Chemistry |5 |

| |Organic Pharmaceutical Chemistry 3 |Pharmaceutical Chemistry |6 |

| |Organic Pharmaceutical Chemistry 4 |Pharmaceutical Chemistry |7 |

| | Advanced Pharmaceutical Analysis |Pharmaceutical Chemistry |8 |

| | | |9 |

• Fifth, Thesis which was supervised by :

|Year |Department |Thesis Title |No. |

|2008 |Pharmaceutical |Cephalothin as a Carriers of 6-Mercaptopurine for Targeting Cancer Tissues. |1 |

| |Chemistry | | |

| | | | |

| | |of 6-Mercaptopurine for Targeting Cancer Tissues | |

| | | | |

| | | | |

| | | | |

| | | | |

|2009 |Pharmaceutical |Synthesis of New 5-Fluorouracil Derivative as Possible Prodrug for Targeting Cancer |2 |

| |Chemistry |Cells | |

|2010 |Pharmaceutical |Design and Synthesis of Dithiocarbamate Derivatives of Thiadiazole and Triazole as |3 |

| |Chemistry |anticopper for Targeting Colon Cancer | |

|2010 |Pharmaceutical |Synthesis of Phosphoramidate Derivative of 5-Fluorouracil as a Possible Prodrugs for|4 |

| |Chemistry |Targeting Cancer Tissue | |

|2011 |Pharmaceutical |Synthesis of 5-Fluorouracil Derivatives Possible Mutual Prodrugs |5 |

| |Chemistry |with Meloxicam and Ibuprofen for Tageting Cancer Tissues | |

|2011 |Pharmaceutical |Synthesis of 5- fluorouracil derivatives as possible mutual prodrug |6 |

| |Chemistry |With melxicam and ibuprofen for targeting cancer tissues | |

|2011 |Pharmaceutical |Synthesis of dithiocarbamate derivatives of ((nitrophenyl)diazenyl |7 |

| |Chemistry |-1,3,4-thiadiazol as possible anticancer agent | |

|2013 |Pharmaceutical |Synthesis of 2,3-Dihydro-1,4-naphthaquinone Derivatives for Targeting the Altered |8 |

| |Chemistry |Cancer Cells Metabolism | |

|2013 |Pharmaceutical |Synthesis of 5-Fluorouracil, 6-Mercaptopurine and Naproxen Conjugates as Possible |9 |

| |Chemistry |Mutual Prodrugs for Targeting Cancer Tissues | |

|2014 |Pharmaceutical |Design and Synthesis of azo Derivatives of 5-Fluorouacil for Targeting Colon Cancer |10 |

| |Chemistry | | |

|2014 |Pharmaceutical |Synthesis of Polymeric Analogue of 6-Mercaptopurine as a Possible Prodrug for |11 |

| |Chemistry |Targeting Cancer Cells | |

|2014 |Pharmaceutical |Synthesis and preliminary kinetic study of 5-fluorouracil derivatives for |12 |

| |Chemistry |Targeting colon tumer | |

|2014 |Pharmaceutical |Design,synthesis and preliminary pharmacological evaluation of new2-azetidinone |13 |

| |Chemistry |derivative of naproxin | |

|2015 |Pharmaceutical |Design, Synthesis and Pharmacological Evaluation of |14 |

| |Chemistry |Sulfanilamide-Ciprofloxacin Conjugates Utilizing Hybridization | |

| | |Approach as New Antibacterial Agents | |

|2015 |Pharmaceutical |Design,synthesis,characterization and preliminary pharmacological anticancer |15 |

| |Chemistry |evaluation of methotrexate silibinine conjugate | |

|2016 |Pharmaceutical |Synthesis, characterization and preliminary antimicrobial evaluation of new |16 |

| |Chemistry |derivative of ceftazidime | |

|2016 |Pharmaceutical |Synthesis of new sulfonamide derivative as possible as possible anticancer agents |17 |

| |Chemistry | | |

|2017 |Pharmaceutical |Synthesis of New Sulfonamide Derivatives as Possible AnAgents |18 |

| |Chemistry | | |

|2017 |Pharmaceutical |Synthesis, Characterization and Preliminary Antibacterial Evaluation of New |19 |

| |Chemistry |Derivatives of Ceftazidime | |

|2017 |Pharmaceutical |Synthesis, Characterization and in vitro evaluation of the anticancer activity of |20 |

| |Chemistry |new HA–based HDAC inhibitors containing amino acids and analides as a surface | |

| | |recognition moieties | |

|2018 |Pharmaceutical |Synthesis of new phthalimide derivatives utilizing hybridization model as |21 |

| |Chemistry |antidiabetic agents | |

|2019 |Pharmaceutical |Synthesis and Preliminary Anticancer Evaluation of 6-Mercaptopurine –Methotrexate |22 |

| |Chemistry |Conjugate as Possible Mutual Prodrug | |

|2019 |Pharmaceutical |Synthesis, Characterization and Preliminary Anticancer Study of Novel 5-fluorouracil|23 |

| |Chemistry |Conjugate with Pyrrolidine Dithiocarbamate as a Mutual Anticancer Prodrug | |

• Sixth, Conferences which you participated:

|Type of Participation |Place |Year |Conferences Title |No. |

| | | | |( بحث / |

| | | | |بوستر حضور)|

|Participant |Baghdad-Iraq |2002 |The 6th scientific conference of college of |2 |

| | | |Pharmacy, Baghdad University | |

|Participant |Baghdad-Iraq |2010 |The 10th scientific conference of college of |3 |

| | | |Pharmacy, Baghdad University | |

|Participant |Baghdad-Iraq |2011 |The 1st scientific conference of college of |4 |

| | | |Pharmacy, Al-mustansiria University | |

|Participant |Baghdad-Iraq |2014 |The 11th scientific conference of college of |5 |

| | | |Pharmacy, Baghdad University | |

|Participant |Baghdad-Iraq |2014 |The scientific conference world of medical |6 |

| | | |city center | |

|Participant |Baghdad-Iraq |2015 |The scientific conference world of medical |7 |

| | | |city center | |

• Seventh, Scientific Activities:

|Outside the College |Within the College |

|Member of manumission cast scientific journal Tekreet University |Chairman of scientific committee of ph.ch. |

|Member of manumission cast scientific journal karbla |Member of scientific committee of college |

|Member of scientific upgrades Baghdad college |Member of manumission cast scientific journal |

| |Chairman of FPGEE |

• Eighth, Research Projects in The Felid of Specialization to The Environment and Society or the Development of Education:

|No. |Research Title |Place of Publication |Year |

|1 |Cephalothin as a carrier of 6- mercaptopurine for |Iraqi Journal of Pharmaceutical Sciences |2009 |

| |targeting Cancer tissues. | | |

|2 |Synthesis of phosphoramidate derivatives of |مجلة جامعة النهرين |2009 |

| |5-flurouracil as A possible prodrugs for targeting | | |

| |cancer tissue. | | |

| | | | |

| |Synthesis of new 5-fluorouracil derivatives as |مجلة علوم المستنصرية |2009 |

| |possible prodrug for targeting cancer tissue | | |

| |Synthesis and preliminary pharmacological study of |Iraqi Journal of Pharmaceutical Sciences |2009 |

| |sulfonamide Conjugates with ibuprofen and indomethacin| | |

| |as new anti- | | |

| |Inflammatory agents. | | |

| | | | |

| |Synthesis of new (dithiperoxo) thioate derivatives of |مجلة جامعة بابل |2010 |

| |6-mercaptopurine as | | |

| |Possible dual acting prodrug for targeting cancer | | |

| |cells | | |

| |DESIGN, SYNTHESIS, AND HYDROLYSIS STUDY OF MUTUAL |Pharmacie Globale |2010 |

| |PRODRUGS OF NSAIDS WITH DIFFERENT ANTIOXIDANTS VIA | | |

| |GLYCOLIC ACID SPACER | | |

| |Synthesis of dithiocarbamate derivatives of |مجلة علوم المستنصرية |2011 |

| |((nitrophenyl)diazenyl | | |

| |-1,3,4-thiadiazol as possible anticancer agent | | |

| |Synthesis of 5- fluorouracil derivatives as possible |Iraqi Journal of Pharmaceutical Sciences |2011 |

| |mutual prodrug | | |

| |With melxicam and ibuprofen for targeting cancer | | |

| |tissues | | |

| |Design, Synthesis and Preliminary Pharmacological |Molecules |2012 |

| |Evaluation of New Non-Steroidal Anti-Inflammatory | | |

| |Agents Having a 4-(Methylsulfonyl) Aniline | | |

| |Pharmacophore | | |

| |Synthesis of new two derivatives of 6-mercaptopurine |International journal pharmaceutical sciences|2012 |

| |6-[5-pyridine |and research | |

| |-4-yl-1,2,3,4-oxadiazole 2-yl)dithol]-9H-purine(38) | | |

| |and 9H-purine-6- | | |

| |Yl-benzyldithiocarbamate(45) with cytotoxicity result | | |

| |from the | | |

| |National center institutes anticancer drug screen | | |

| |Synthesis of 2,3-Dihydro-1,4-naphthaquinone |Journal of Advances in Chemistry |2013 |

| |Derivatives for Targeting the Altered Cancer Cells | | |

| |Metabolism | | |

| |Design and Synthesis of azo Derivatives of |Journal of Advances in Chemistry |2014 |

| |5-Fluorouacil for Targeting Colon Cancer | | |

| |Design, Synthesis and Pharmacological Evaluation of |Journal of Natural Sciences Research |2015 |

| |Sulfanilamide-Ciprofloxacin Conjugates Utilizing | | |

| |Hybridization | | |

| |Approach as New Antibacterial Agents | | |

| | | |2016 |

| |Synthesis of New Sulfonamide Derivatives as Possible |Der Pharmacia Lettre | |

| |Antibacterial Agents | | |

| | | |2017 |

| |Synthesis, Characterization, and in vitro evaluation |Der Pharmacia Lettre | |

| |of the anticancer activity of new HA–based HDAC | | |

| |inhibitors containing amino acids and analides as a | | |

| |surface recognition moieties | | |

| |Synthesis of New Sulfonamide Derivatives-phenylalanine|Int. J. Pharm. Sci. Rev. Res. |2017 |

| |and Proline Ester Conjugate using Maleamide Spacer as | | |

| |Anticancer Agents | | |

| |Synthesis of New Sulfonamide Derivatives-Phenylalanine|Der Pharmacia Lettre |2017 |

| |and Proline Ester Conjugate | | |

| |Using Succinamide Spacer as Anticancer Agents | | |

| | |International journal of Chem Tech Research |2017 |

| |Synthesis, Characterization and in vitro evaluation of| | |

| |the anticancer activity of new HA–based HDAC | | |

| |inhibitors containing amino acids and analides as a | | |

| |surface | | |

| |recognition moieties | | |

| |Synthesis, Characterization and in vitro evaluation of|Journal of Advances in Chemistry |2017 |

| |anticancer activity | | |

| |of new hydroxamicacid basedHDACis | | |

| |containingsubstitutedThaidiazole | | |

| |as a cap linking moiety | | |

| | |Journal of Pharmaceutical Sciences and |2018 |

| |Synthesis, Characterization and Preliminary ᾀ |Researech | |

| |-Glucosidase Inhibition Study of | | |

| |4-(1,3-dioxoisoindolin-2-yl)butanamide Derivatives | | |

| |Synthesis, Characterization and ᾀ -Glucosidase | |2018 |

| |Inhibition activity of New |Iraqi Journal of Pharmaceutical Sciences | |

| |Phthalimide Derivatives | | |

| |Synthesis and Preliminary Anticancer Evaluation of |Iraqi Journal of Pharmaceutical Sciences |2019 |

| |6-Mercaptopurine –Methotrexate Conjugate as Possible | | |

| |Mutual Prodrug | | |

• Ninth, Membership:

➢ Chairman of scientific committee of ph.ch.

➢ Member of scientific committee of college

➢ Member of manumission cast scientific journal

➢ Chairman of FPGEE

➢ Member of manumission cast scientific journal pharmacy college karbla University

➢ Member of scientific upgrades Baghdad college

•

• Tenth, Awards and Certificates of Appreciation:

|Year |Donor |Name of Awards and Certificates |No. |

| |Collegeof pharmacy/Baghdad |ten letters of Acknowledgment |1 |

| |Baghdad university |Two letters of Acknowledgment |2 |

| |Ministry of higher education |Two letters of Acknowledgment |3 |

| |Leadership of ministry |One letters of Acknowledgment |4 |

| | | |5 |

| | | |6 |

• Eleventh, Scientific literature:

|Year of The Publication |Scientific Literature Title |No. |

|2017 |Design and synthesis of novel anti-tuberculosis agent |1 |

| | |2 |

| | |3 |

• Twelfth, languages:

✓ Arabic

✓ English

*Note: - Make a copy on CD.[pic][pic][pic]

-----------------------

[pic]

Ph oto

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download